Sign In
Buy NKTR
$59.23
+0.670 (+1.14%)
At Close: Jun 03, 2026
Nektar's (NKTR) Q3 Earnings and Revenues Beat Estimates
02:20pm, Friday, 04'th Nov 2022
Nektar (NKTR) reports encouraging third-quarter 2022 results. The narrower-than-expected loss is on account of lower operating expenses incurred during the quarter.
Nektar Therapeutics (NKTR) Q3 2022 Earnings Call Transcript
11:15pm, Thursday, 03'rd Nov 2022
Nektar Therapeutics (NASDAQ:NKTR ) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Vivian Wu - Director, Investor Relations and Corporate Affairs Howard Robin - Presi
Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates
08:20pm, Thursday, 03'rd Nov 2022
Nektar (NKTR) delivered earnings and revenue surprises of 48.94% and 1.35%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
SAN FRANCISCO , Oct. 25, 2022 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2022 on Thursday, November 3, 2022, after the close of U.S.-b
PureTech Health and Nektar Therapeutics end tie-up talks
05:13am, Tuesday, 11'th Oct 2022
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF) PLC and Nektar Therapeutics (NASDAQ:NKTR) said they have mutually agreed to terminate discussions regarding a possible combination of the two compani
3 Penny Stocks Trading Strategies You Need to Consider
11:00am, Saturday, 08'th Oct 2022
Check these penny stocks trading strategies out this week The post 3 Penny Stocks Trading Strategies You Need to Consider appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc
Best Penny Stocks To Buy Now? 4 Biotech Stocks To Watch
02:06pm, Friday, 07'th Oct 2022
Best penny stocks to buy? Biotech penny stocks are heating up & these 4 might be worth watching now.
PureTech Health confirms ‘possible combination' with Nektar Therapeutics
03:36am, Friday, 07'th Oct 2022
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF) PLC has confirmed that it is in talks about a possible tie-up with Nektar Therapeutics (NASDAQ:NKTR), Inc. Responding to press speculation, PureTec
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
10:20am, Thursday, 08'th Sep 2022 Zacks Investment Research
Smart Beta ETF report for XPH
Nektar.ai exits stealth mode to plug CRM data leakages
08:30pm, Tuesday, 06'th Sep 2022
A lot of important data gets lost along the sales pipeline because sales teams use multiple tools, including email, Zoom and WhatsApp, to talk with buyers. Nektar.
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
10:20am, Tuesday, 06'th Sep 2022 Zacks Investment Research
Sector ETF report for XPH
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
02:10pm, Monday, 08'th Aug 2022 Benzinga
Upgrades
For iRobot Corp (NASDAQ:IRBT), JP Morgan upgraded the previous rating of Underweight to Neutral. In the second quarter, iRobot showed an EPS of $0.35, compared to $0.27 from the year-ago qua
Nektar's (NKTR) Q2 Earnings and Revenues Miss Estimates
04:11pm, Friday, 05'th Aug 2022 Zacks Investment Research
Nektar (NKTR) reports dismal second-quarter 2022 results. The company's operating expenses increased due to restructuring expenses of $106.0 million incurred during the quarter.
Nektar's (NKTR) Q2 Earnings and Revenues Miss Estimates
01:33pm, Friday, 05'th Aug 2022
Nektar (NKTR) reports dismal second-quarter 2022 results. The company's operating expenses increased due to restructuring expenses of $106.0 million incurred during the quarter.
Nektar Therapeutics (NKTR) Reports Q2 Loss, Lags Revenue Estimates
10:15pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Nektar (NKTR) delivered earnings and revenue surprises of 15.84% and 7.01%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
